Table 4.
Clinical features of patients with response to the treatment.
| pCR (n=13) | Non-pCR (n=13) | p | |
|---|---|---|---|
| Age, years, n (%) | 0.030* | ||
| <50 | 4 (30.8) | 0 (0) | |
| ≥50 | 9 (69.2) | 13 (100) | |
| Sex, n (%) | 0.431 | ||
| Male | 6 (46.2) | 8 (61.5) | |
| Female | 7 (53.9) | 5 (38.5) | |
| CEA level, ng/ml, n (%) | 0.004** | ||
| <5 | 12 (92.3) | 5 (38.5) | |
| ≥5 | 1 (7.7) | 8 (61.5) | |
| Differentiation grade | 0.095 | ||
| 1 | 3 (23.1) | 0 (0) | |
| 2 | 9 (69.2) | 13 (100) | |
| 3 | 1 (7.7) | 0 (0) | |
| Clinical T classification, n (%) | 0.619 | ||
| 1-2 | 3 (23.1) | 2 (15.4) | |
| 3-4 | 10 (76.9) | 11 (84.6) | |
| Clinical N classification, n (%) | 1 | ||
| Negative | 6 (46.2) | 6 (46.2) | |
| Positive | 7 (53.9) | 7 (53.9) | |
| Distance from AV (cm), n (%) | 0.431 | ||
| <5 | 7 (53.9) | 5 (35.5) | |
| 5-10 | 6 (46.2) | 8 (61.5) | |
| EMVI, n (%) | 0.680 | ||
| Negative | 5 (38.5) | 4 (30.8) | |
| Positive | 8 (61.5) | 9 (69.2) | |
| MRF, n (%) | 0.277 | ||
| Negative | 10 (76.92) | 12 (92.3) | |
| Positive | 3 (23.08) | 1 (7.7) | |
| Radiotherapy-surgery interval, weeks, n (%) | 0.216 | ||
| ≥7 | 7 (53.9) | 10 (76.9) | |
| <7 | 6 (46.2) | 3 (23.1) |
*p<0.05, **p<0.01.